...
search icon
naut-img

Nautilus Biotechnology Inc Share Price

NAUT
NAQ
$2.19
+$0.06
(2.82%)
1D
Industry: Biotechnology Sector: Health Care

Nautilus Biotechnology Inc Analyst Forecast

Nautilus Biotechnology Inc Share Price Chart

Nautilus Biotechnology Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$269.03M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
142.15K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.36
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.62 L
$2.54 H
$2.19

About Nautilus Biotechnology Inc, Common Stock

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes an end-to-end solution comprising instruments, consumables, and software analysis. It also offers a proteome analysis system, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent probe binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers reagent kits, which include sample preparation, flow cells, multi-affinity probe reagents, and instrument buffer system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. and Weill Cornell Medicine"Qatar have a research collaboration with The Michael J. Fox Foundation to study the connection between the alpha-synuclein (aSyn) protein and Parkinson's disease (PD). Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington. more

Industry: BiotechnologySector: Health Care

Nautilus Biotechnology Inc Stock Returns

Time FrameNAUTSectorS&P500
1-Week Return7.88%-1.08%-1.38%
1-Month Return11.73%-0.47%-1.81%
3-Month Return15.87%2.13%1.38%
6-Month Return206.21%17.04%5.68%
1-Year Return27.33%6.56%11.74%
3-Year Return10.05%16.78%65.15%
5-Year Return-87.38%34.34%73.68%
10-Year Return-79.02%137.88%260.03%

Nautilus Biotechnology Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue2.35M2.84M3.42M5.71M6.35M[{"date":"2020-12-31","value":36.93,"profit":true},{"date":"2021-12-31","value":44.73,"profit":true},{"date":"2022-12-31","value":53.77,"profit":true},{"date":"2023-12-31","value":89.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(2.35M)(2.84M)(3.42M)(5.71M)(6.35M)[{"date":"2020-12-31","value":-234600000,"profit":false},{"date":"2021-12-31","value":-284200000,"profit":false},{"date":"2022-12-31","value":-341600000,"profit":false},{"date":"2023-12-31","value":-570500000,"profit":false},{"date":"2024-12-31","value":-635300000,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Operating Expenses13.40M47.66M60.20M70.45M75.12M[{"date":"2020-12-31","value":17.83,"profit":true},{"date":"2021-12-31","value":63.44,"profit":true},{"date":"2022-12-31","value":80.14,"profit":true},{"date":"2023-12-31","value":93.78,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(15.74M)(50.50M)(63.62M)(76.15M)(81.48M)[{"date":"2020-12-31","value":-1574400000,"profit":false},{"date":"2021-12-31","value":-5049800000,"profit":false},{"date":"2022-12-31","value":-6361800000,"profit":false},{"date":"2023-12-31","value":-7615200000,"profit":false},{"date":"2024-12-31","value":-8147600000,"profit":false}]
Total Non-Operating Income/Expense-512.00K11.51M24.88M21.48M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":2.06,"profit":true},{"date":"2022-12-31","value":46.26,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":86.31,"profit":true}]
Pre-Tax Income(15.62M)(50.31M)(57.92M)(63.67M)(70.78M)[{"date":"2020-12-31","value":-1561900000,"profit":false},{"date":"2021-12-31","value":-5031500000,"profit":false},{"date":"2022-12-31","value":-5792400000,"profit":false},{"date":"2023-12-31","value":-6367500000,"profit":false},{"date":"2024-12-31","value":-7078000000,"profit":false}]
Income Taxes2.14M2.61M5.82M-(70.78M)[{"date":"2020-12-31","value":36.79,"profit":true},{"date":"2021-12-31","value":44.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-1216.99,"profit":false}]
Income After Taxes-(52.92M)(63.74M)--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(15.62M)(50.31M)(57.92M)(60.06M)(70.78M)[{"date":"2020-12-31","value":-1561900000,"profit":false},{"date":"2021-12-31","value":-5031500000,"profit":false},{"date":"2022-12-31","value":-5792400000,"profit":false},{"date":"2023-12-31","value":-6006000000,"profit":false},{"date":"2024-12-31","value":-7078000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(15.62M)(50.31M)(57.92M)(63.67M)(70.78M)[{"date":"2020-12-31","value":-1561900000,"profit":false},{"date":"2021-12-31","value":-5031500000,"profit":false},{"date":"2022-12-31","value":-5792400000,"profit":false},{"date":"2023-12-31","value":-6367500000,"profit":false},{"date":"2024-12-31","value":-7078000000,"profit":false}]
EPS (Diluted)(0.03)(0.79)(0.47)(0.52)(0.56)[{"date":"2020-12-31","value":-3,"profit":false},{"date":"2021-12-31","value":-79,"profit":false},{"date":"2022-12-31","value":-47,"profit":false},{"date":"2023-12-31","value":-52,"profit":false},{"date":"2024-12-31","value":-56,"profit":false}]

Nautilus Biotechnology Inc Ratios

Nautilus Biotechnology Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

NAUT
Cash Ratio 14.63
Current Ratio 14.95

Nautilus Biotechnology Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NAUT
ROA (LTM) -19.37%
ROE (LTM) -32.00%

Nautilus Biotechnology Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NAUT
Debt Ratio Lower is generally better. Negative is bad. 0.16
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.84

Nautilus Biotechnology Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NAUT
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.59
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Nautilus Biotechnology Inc share price today?

Nautilus Biotechnology Inc (NAUT) share price today is $2.19

Can Indians buy Nautilus Biotechnology Inc shares?

Yes, Indians can buy shares of Nautilus Biotechnology Inc (NAUT) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NAUT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Nautilus Biotechnology Inc be purchased?

Yes, you can purchase fractional shares of Nautilus Biotechnology Inc (NAUT) via the Vested app. You can start investing in Nautilus Biotechnology Inc (NAUT) with a minimum investment of $1.

How to invest in Nautilus Biotechnology Inc shares from India?

You can invest in shares of Nautilus Biotechnology Inc (NAUT) via Vested in three simple steps:

  • Click on Sign Up or Invest in NAUT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Nautilus Biotechnology Inc shares
What is Nautilus Biotechnology Inc 52-week high and low stock price?

The 52-week high price of Nautilus Biotechnology Inc (NAUT) is $2.54. The 52-week low price of Nautilus Biotechnology Inc (NAUT) is $0.62.

What is Nautilus Biotechnology Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Nautilus Biotechnology Inc (NAUT) is

What is Nautilus Biotechnology Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Nautilus Biotechnology Inc (NAUT) is 1.59

What is Nautilus Biotechnology Inc dividend yield?

The dividend yield of Nautilus Biotechnology Inc (NAUT) is 0.00%

What is the Market Cap of Nautilus Biotechnology Inc?

The market capitalization of Nautilus Biotechnology Inc (NAUT) is $269.03M

What is Nautilus Biotechnology Inc's stock symbol?

The stock symbol (or ticker) of Nautilus Biotechnology Inc is NAUT

How Can Investors Use Nautilus Biotechnology Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Nautilus Biotechnology Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Nautilus Biotechnology Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Nautilus Biotechnology Inc shares for Indian investors?

When investing in Nautilus Biotechnology Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Nautilus Biotechnology Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Nautilus Biotechnology Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Nautilus Biotechnology Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Nautilus Biotechnology Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top